Hence, if overexpression of PLK1 for patients with pancreatic cancer after pancreatectomy was detected, non-gemcitabine chemotherapy would be preferred to avoid potential chemotherapeutic resistance. The gene discussed is PLK1; the disease is pancreatic neoplasm.